Back to search
FDAFDA · Food and drugs·Recall number Z-1266-2023

Attune Revision Limb Preservation System (LPS) Tibial Insert SM 12MM, Part Number 151760312

Published March 29, 2023 · Recall initiated: February 15, 2023

Summary

FDA records medical device Class II recall Z-1266-2023, published March 29, 2023 and initiated February 15, 2023. Recalling firm: DePuy Orthopaedics, Inc.; Status: Ongoing; Reported quantity: 7 units; Lot: GTIN: 10603295490869; Lot: JP6464. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The subject product lots are being recalled because they received a higher than specified irradiation dose. This exceeds the validated range for exposure to gamma radiation of these devices and may result in changes to the implant material properties.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
DePuy Orthopaedics, Inc.
Distributor
Worldwide distribution - US Nationwide and the countries of Canada, Poland, Germany, India, Australia, & New Zealand
Lot
GTIN: 10603295490869; Lot: JP6464
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Attune Revision Limb Preservation System (LPS) Tibial Insert SM 12MM, Part Number 151760312 recalled?

Yes. FDA published recall Z-1266-2023 on March 29, 2023. Reported hazard: The subject product lots are being recalled because they received a higher than specified irradiation dose. This exceeds the validated range for exposure to gamma radiation of these devices and may result in changes to the implant material properties.

What should I do if I have this product?

Voluntary: Firm initiated · Letter